Correlation Between Oric Pharmaceuticals and Traws Pharma

Can any of the company-specific risk be diversified away by investing in both Oric Pharmaceuticals and Traws Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oric Pharmaceuticals and Traws Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oric Pharmaceuticals and Traws Pharma, you can compare the effects of market volatilities on Oric Pharmaceuticals and Traws Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oric Pharmaceuticals with a short position of Traws Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oric Pharmaceuticals and Traws Pharma.

Diversification Opportunities for Oric Pharmaceuticals and Traws Pharma

0.57

Correlation Coefficient

Oric Pharmaceuticals  Traws Pharma

Very weak diversification

The 3 months correlation between Oric and Traws is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and Traws Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Traws Pharma and Oric Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oric Pharmaceuticals are associated (or correlated) with Traws Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Traws Pharma has no effect on the direction of Oric Pharmaceuticals i.e., Oric Pharmaceuticals and Traws Pharma go up and down completely randomly.

Pair Corralation between Oric Pharmaceuticals and Traws Pharma

Given the investment horizon of 90 days Oric Pharmaceuticals is expected to generate 0.94 times more return on investment than Traws Pharma. However, Oric Pharmaceuticals is 1.06 times less risky than Traws Pharma. It trades about 0.04 of its potential returns per unit of risk. Traws Pharma is currently generating about -0.06 per unit of risk. If you would invest  637.00  in Oric Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of  184.00  from holding Oric Pharmaceuticals or generate 28.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	99.66%
Values	Daily Returns

Oric Pharmaceuticals  vs.  Traws Pharma

Oric Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oric Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Traws Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Traws Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Oric Pharmaceuticals and Traws Pharma

The main advantage of trading using opposite Oric Pharmaceuticals and Traws Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oric Pharmaceuticals position performs unexpectedly, Traws Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Traws Pharma will offset losses from the drop in Traws Pharma's long position.

The idea behind Oric Pharmaceuticals and Traws Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.